|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/24 |
| (11) | Number of the document | 2274009 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09725345.4 |
| Date of filing the European patent application | 2009-03-27 | |
| (97) | Date of publication of the European application | 2011-01-19 |
| (45) | Date of publication and mention of the grant of the patent | 2013-11-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/038509 |
| Date | 2009-03-27 |
| (87) | Number | WO 2009/120927 |
| Date | 2009-10-01 |
| (30) | Number | Date | Country code |
| 40363 P | 2008-03-28 | US |
| (72) |
HARGREAVE, Fredrick, E., CA
VENTRESCA, Giampietro, GB
|
| (73) |
GlaxoSmithKline LLC,
One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102,
US
|
| (54) | METHODS OF TREATMENT |
| METHODS OF TREATMENT |